Introduction
Duchenne and Becker muscular dystrophies (DMD/ BMD) are allelic, X-linked, recessive neuromuscular disorders caused by mutations in the dystrophin gene located at Xp21.1. Due to the X-linked nature of the disorder, males carrying the mutated gene are spontaneously affected, while females become carriers of the disease. DMD is a common disease affecting 1/3500 male births, while BMD is milder and less frequent. Diagnosis of patients with DMD/ BMD is usually definitive based on clinical, pathological and biochemical findings, although it is increasingly being confirmed by molecular analysis. Due to the extremely large size of the gene (2.4 Mb), the majority of the mutations have been identified as deletions (65 %) or duplications (5 %) (5, 7) . The deletions in the dystrophin gene are non-randomly distributed in two regions, at the 5' terminus (minor "hotspot") and in the distal half of the central rod domain around exons 44-53 (major "hotspot") (3, 7) . Mutations that disrupt the open reading frame (ORF) are known to cause DMD, whereas those which maintain it have been suggested to result in BMD. It presents with muscular weakness, hypertrophy of the calf muscles, positive Gower's sign, and Pradhan's valley sign. We report, a female presenting with weakness in the lower limbs and bulkiness of both calves who was admitted to the neurology ward, PGIMER, Chandigarh. She presented with a positive family history including an affected son who was diagnosed as having DMD. Genetic analysis of dystrophin loci of this female and her son was conducted. PCR-SSCP and sequencing analysis were also performed to study the role of genetic polymorphism. Results revealed point mutations in the dystrophin gene in the carrier and her son, strongly indicating that the female is a manifesting DMD carrier.
Case report
A 35-year old lady was admitted with a history suggestive of insidious onset, proximal weakness in the lower limbs and bulkiness of both calves since ten years of age. The weakness progressed with gradual involvement of truncal muscles and later proximal muscles in the upper limbs over the next 8-10 years. She denied any history of neck or facial weakness, dysphagia, ptosis or diplopia, stiffness, wasting, twitchings, contractures, cramps or exercise intolerance, sensory, urinary, respiratory or cardiac symptoms. There was no history suggestive of diabetes, hypothyroidism or chronic drug intake. Her birth or developmental history was not available. Family history revealed that her elder brother suffered from a similar weakness and bulkiness of calves starting in early childhood. His symptoms had gradually progressed to a bed bound state causing death by 17 years of age. Her 9 year old younger son also exhibited bulky calves and has developed similar symptoms for the last 4-5 years. A detail of their older generations was not available. Her neurological examination revealed bulky calves with a rubbery feel on palpation, positive valley sign, neck flexor muscle weakness, grade 3/5 (MRC grading) 4+/5 power proximally and distally in all the limbs coupled with hyporeflexia in the upper limbs and normal reflexes in the lower limbs. There were no contractures and mentation cranial nerve; sensory, cerebellar and cardiac examinations were normal. Her hemogram, biochemistry (including fasting blood sugar, renal parameters and serum electrolytes), electrocardiogram and ECHO were normal. Serum CPK couldn't be done since the patient had undergone FNAC procedure from calves 4 days prior to admission. Electromyography (EMG) revealed myopathic changes. Her muscle biopsy was suggestive of mild muscular dystrophy. Clinically, her son revealed bulky calves, positive valley sign 167 
CASE REPORT

A CASE OF MANIFESTING CARRIER WITH DMD PHENOTYPE
Akshay Anand, Monika Vinish, Sudesh Prabhakar
Departments of Neurology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India
Summary: A case of a 35-year old female with a history of proximal weakness in lower limbs and bulkiness of both calves manifesting before ten years of age was reported. Clinical findings were suggestive of muscular dystrophy. Genetic analysis using polymerase chain reaction (PCR), single strand conformation polymorphism (SSCP) and direct sequencing revealed several point mutations, which account for dystrophin dysfunction and DMD type pathogenesis. Hence, the clinical possibility of dystrophinopathy in view of the pattern of inheritance became a consideration for the son and manifest carrier for the mother.
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Genomic DNA from the peripheral blood lymphocytes was isolated using the established phenol chloroform isolation method (12) . It was quantitated and analysed for its integrity in 2 % agarose gel electrophoresis. DNA of both mother and son was amplified for specific dystrophin gene by using a set of primers reported earlier (1), followed by SSCP and direct sequencing of the purified PCR products. The sequences obtained from these DMD patients were compared with sequences from the normal individuals. These were compared with the published sequences from pubmed and other gene bank databases.
PCR analysis has revealed the absence of exons 8, 12, 17, 19, in the son while all the exons were intact in the mother (Fig. 1-4) . When the amplified PCR products were subjected to SSCP, they exhibited significant differential mobility indicating heterozygous mutations. On sequencing, the PCR products of both mother and son revealed a number of point mutations (Tab. 1); some transitions were common in exon 4.
Discussion
Molecular genetics approaches have made it possible to establish a precise diagnosis and female carrier detection (10) . However, carrier analysis by molecular methods in females is still difficult due to the presence of a normal copy of the gene in the hetrerozygous carrier females (9) . Duchenne muscular dystrophy, being an X-linked recessive disorder rarely affects females, who usually act as non manifesting carriers. In this case, a 35-year-old female with clinically expressing DMD phenotype is reported In the present report, a combination of PCR, SSCP and sequencing was utilized to screen the mutations in the dystrophin loci and revealed that the mother exhibited frame shift mutation in the dystrophin gene, while her son exhibited both exonic deletions as well as point mutations in the same loci (Tab. 1). DMD manifest carrier is a rare case and this report represents the first clinical-molecular description from South-East Asia. (11) These "isolated carriers" are reported to represent about 10 % of women with high serum creatine phosphokinase (CPK) levels with evident muscle involvement.
Several factors responsible for muscular dystrophy in a manifest female carrier include the presence of mutations in both alleles of Xp21.1. This also includes the possibility of Turner's syndrome generating such a clinical picture. However, features representative of this were found to be completely absent in this case. The shielding effect exerted through the normal X allele appears to be lost in such manifesting carriers as this. Different approaches have been used for the identification of female carriers where deletions are not detectable by PCR. These include multiple ligation probe amplification (MLPA) for the identification of female carriers of DMD deletions or duplications (4). Point mutations detected by SSCP and PCR, particularly in exon 44 and 45 in both mother and son, seem to have altered the protein structure. In the present case the mutations were detected in the ORF, which might be responsible for the pathogenesis this case. Similarly the presence of common transition mutations in exon 4 of both mother and son, some novel point mutations, might be causal of DMD phenotype.
The severity of the disease is well known to be causally linked with the type and severity of mutations. It has earlier been reported that about 60 % of both Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are caused due to deletions of the dystrophin gene (6) . The "reading frame" hypothesis predicts that BMD patients produce a semifunctional, internally deleted dystrophin protein, whereas DMD patients produce a severely truncated protein that is unstable. Alternate splicing can also produce an unpredictable coding sequence as reported in earlier studies (2) . Thus, we can speculate that these point mutations in the mother might be responsible for alterations of the reading frame and hence the DMD type phenotype. 
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